Publication | Closed Access
Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results
161
Citations
48
References
2023
Year
Cell TherapyRefractory NeuroblastomaMedicineImmunologyTrial Interim ResultsImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyAnti-gd2 Car-nkt Cells
| Year | Citations | |
|---|---|---|
Page 1
Page 1